Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes

Summary The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of hospital infection 2008-12, Vol.70 (4), p.305-313
Hauptverfasser: Nimmo, G.R, Fong, J, Paterson, D.L, McLaws, M.-L
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 313
container_issue 4
container_start_page 305
container_title The Journal of hospital infection
container_volume 70
creator Nimmo, G.R
Fong, J
Paterson, D.L
McLaws, M.-L
description Summary The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is necessary to guide clinical and public health action. Here we report passive surveillance of all public laboratory susceptibility data in Queensland to track changes in MRSA phenotypes corresponding to the major epidemic strains from 2000 to 2006. The inpatient rate of MRSA isolation from pus, tissue and fluid (PTF) and blood culture (BC) specimens declined by 26% and 35%, respectively. The rate of isolation of the AUS-2/3-like phenotype (corresponding to ST239-MRSA-III) decreased from 651 to 242 isolates per million accrued patient days in inpatient PTF and BC, whereas that for non-multiresistant MRSA (nmMRSA, corresponding to community MRSA strains) increased from 71 to 315. The overall outpatient rate of MRSA isolation from PTF and BC increased by 224% and 31%, respectively. The rate of AUS-2/3-like isolates in outpatient PTF decreased from 131 to 60 per million outpatient occasions of service while the nmMRSA rate increased from 52 to 490. Surveillance of phenotypes derived from routine susceptibility data is a useful tool for tracking changes in the epidemiology of MRSA over large geographical regions.
doi_str_mv 10.1016/j.jhin.2008.07.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69821963</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0195670108003034</els_id><sourcerecordid>69821963</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-91d72751cf4e3bef12cb3da20fc27fa36a0f61c0bd947b4b9ed6b42d86b6327b3</originalsourceid><addsrcrecordid>eNp9Usuq1EAQDaJ4x6s_4EJ6o6ubWN2dyUNEuAy-4ILI1XXT6VRmesx0Yld6IDv_wYX_55fYcQYFF64KinNOHc6pJHnMIePAi-f7bL-zLhMAVQZlBiDvJCu-liIVtazvJivg9TotSuAXyQOiPQDE_fp-csGrspJVXq6SH5uddlvrtgxH2-LBDv2wndnQsQNO1ti-ty71SJYm7SZ2mzEdPAZi1rGPAdFRr117xa4DTV73Vl-x6Ad-fvseR_GCBcJFbNRE9oiMgj9iFNXO_N5TIIPjZBvb22lm4w7dMM0j0sPkXqd7wkfneZl8fvP60-ZdevPh7fvN9U1qcllPac3bUpRrbrocZYMdF6aRrRbQGVF2WhYauoIbaNo6L5u8qbEtmly0VdEUUpSNvEyenXRHP3wNSJM62GhpcYhDIFXUleB1ISNQnIDGD0QeOzV6e9B-VhzUUofaq6UOtdShoFSxjkh6clYPzQHbv5Rz_hHw9AzQZHTf-RiMpT84AXUu8qqIuJcnHMYsjha9ImMxhthaj2ZS7WD_7-PVP3QTe7Xx4heckfZD8C6mrLgioUDdLo-z_A1UkQ0yl78AXD3A9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69821963</pqid></control><display><type>article</type><title>Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Nimmo, G.R ; Fong, J ; Paterson, D.L ; McLaws, M.-L</creator><creatorcontrib>Nimmo, G.R ; Fong, J ; Paterson, D.L ; McLaws, M.-L</creatorcontrib><description>Summary The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is necessary to guide clinical and public health action. Here we report passive surveillance of all public laboratory susceptibility data in Queensland to track changes in MRSA phenotypes corresponding to the major epidemic strains from 2000 to 2006. The inpatient rate of MRSA isolation from pus, tissue and fluid (PTF) and blood culture (BC) specimens declined by 26% and 35%, respectively. The rate of isolation of the AUS-2/3-like phenotype (corresponding to ST239-MRSA-III) decreased from 651 to 242 isolates per million accrued patient days in inpatient PTF and BC, whereas that for non-multiresistant MRSA (nmMRSA, corresponding to community MRSA strains) increased from 71 to 315. The overall outpatient rate of MRSA isolation from PTF and BC increased by 224% and 31%, respectively. The rate of AUS-2/3-like isolates in outpatient PTF decreased from 131 to 60 per million outpatient occasions of service while the nmMRSA rate increased from 52 to 490. Surveillance of phenotypes derived from routine susceptibility data is a useful tool for tracking changes in the epidemiology of MRSA over large geographical regions.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2008.07.003</identifier><identifier>PMID: 18783847</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Anti-Bacterial Agents - pharmacology ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Australia ; Biological and medical sciences ; Community-Acquired Infections - epidemiology ; Community-Acquired Infections - microbiology ; Cross Infection - epidemiology ; Cross Infection - microbiology ; Epidemiology ; Humans ; Infectious Disease ; Infectious diseases ; Medical sciences ; Methicillin - pharmacology ; Methicillin-Resistant Staphylococcus aureus - drug effects ; Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification ; Meticillin-resistant S. aureus ; Microbial Sensitivity Tests ; Pharmacology. Drug treatments ; Phenotype ; Population Surveillance - methods ; Queensland - epidemiology ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation &amp; purification ; Surveillance</subject><ispartof>The Journal of hospital infection, 2008-12, Vol.70 (4), p.305-313</ispartof><rights>2008</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-91d72751cf4e3bef12cb3da20fc27fa36a0f61c0bd947b4b9ed6b42d86b6327b3</citedby><cites>FETCH-LOGICAL-c439t-91d72751cf4e3bef12cb3da20fc27fa36a0f61c0bd947b4b9ed6b42d86b6327b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0195670108003034$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20942486$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18783847$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nimmo, G.R</creatorcontrib><creatorcontrib>Fong, J</creatorcontrib><creatorcontrib>Paterson, D.L</creatorcontrib><creatorcontrib>McLaws, M.-L</creatorcontrib><title>Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>Summary The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is necessary to guide clinical and public health action. Here we report passive surveillance of all public laboratory susceptibility data in Queensland to track changes in MRSA phenotypes corresponding to the major epidemic strains from 2000 to 2006. The inpatient rate of MRSA isolation from pus, tissue and fluid (PTF) and blood culture (BC) specimens declined by 26% and 35%, respectively. The rate of isolation of the AUS-2/3-like phenotype (corresponding to ST239-MRSA-III) decreased from 651 to 242 isolates per million accrued patient days in inpatient PTF and BC, whereas that for non-multiresistant MRSA (nmMRSA, corresponding to community MRSA strains) increased from 71 to 315. The overall outpatient rate of MRSA isolation from PTF and BC increased by 224% and 31%, respectively. The rate of AUS-2/3-like isolates in outpatient PTF decreased from 131 to 60 per million outpatient occasions of service while the nmMRSA rate increased from 52 to 490. Surveillance of phenotypes derived from routine susceptibility data is a useful tool for tracking changes in the epidemiology of MRSA over large geographical regions.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Australia</subject><subject>Biological and medical sciences</subject><subject>Community-Acquired Infections - epidemiology</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Cross Infection - epidemiology</subject><subject>Cross Infection - microbiology</subject><subject>Epidemiology</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Methicillin - pharmacology</subject><subject>Methicillin-Resistant Staphylococcus aureus - drug effects</subject><subject>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</subject><subject>Meticillin-resistant S. aureus</subject><subject>Microbial Sensitivity Tests</subject><subject>Pharmacology. Drug treatments</subject><subject>Phenotype</subject><subject>Population Surveillance - methods</subject><subject>Queensland - epidemiology</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><subject>Surveillance</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9Usuq1EAQDaJ4x6s_4EJ6o6ubWN2dyUNEuAy-4ILI1XXT6VRmesx0Yld6IDv_wYX_55fYcQYFF64KinNOHc6pJHnMIePAi-f7bL-zLhMAVQZlBiDvJCu-liIVtazvJivg9TotSuAXyQOiPQDE_fp-csGrspJVXq6SH5uddlvrtgxH2-LBDv2wndnQsQNO1ti-ty71SJYm7SZ2mzEdPAZi1rGPAdFRr117xa4DTV73Vl-x6Ad-fvseR_GCBcJFbNRE9oiMgj9iFNXO_N5TIIPjZBvb22lm4w7dMM0j0sPkXqd7wkfneZl8fvP60-ZdevPh7fvN9U1qcllPac3bUpRrbrocZYMdF6aRrRbQGVF2WhYauoIbaNo6L5u8qbEtmly0VdEUUpSNvEyenXRHP3wNSJM62GhpcYhDIFXUleB1ISNQnIDGD0QeOzV6e9B-VhzUUofaq6UOtdShoFSxjkh6clYPzQHbv5Rz_hHw9AzQZHTf-RiMpT84AXUu8qqIuJcnHMYsjha9ImMxhthaj2ZS7WD_7-PVP3QTe7Xx4heckfZD8C6mrLgioUDdLo-z_A1UkQ0yl78AXD3A9g</recordid><startdate>20081201</startdate><enddate>20081201</enddate><creator>Nimmo, G.R</creator><creator>Fong, J</creator><creator>Paterson, D.L</creator><creator>McLaws, M.-L</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20081201</creationdate><title>Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes</title><author>Nimmo, G.R ; Fong, J ; Paterson, D.L ; McLaws, M.-L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-91d72751cf4e3bef12cb3da20fc27fa36a0f61c0bd947b4b9ed6b42d86b6327b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Australia</topic><topic>Biological and medical sciences</topic><topic>Community-Acquired Infections - epidemiology</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Cross Infection - epidemiology</topic><topic>Cross Infection - microbiology</topic><topic>Epidemiology</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Methicillin - pharmacology</topic><topic>Methicillin-Resistant Staphylococcus aureus - drug effects</topic><topic>Methicillin-Resistant Staphylococcus aureus - isolation &amp; purification</topic><topic>Meticillin-resistant S. aureus</topic><topic>Microbial Sensitivity Tests</topic><topic>Pharmacology. Drug treatments</topic><topic>Phenotype</topic><topic>Population Surveillance - methods</topic><topic>Queensland - epidemiology</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><topic>Surveillance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nimmo, G.R</creatorcontrib><creatorcontrib>Fong, J</creatorcontrib><creatorcontrib>Paterson, D.L</creatorcontrib><creatorcontrib>McLaws, M.-L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nimmo, G.R</au><au>Fong, J</au><au>Paterson, D.L</au><au>McLaws, M.-L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2008-12-01</date><risdate>2008</risdate><volume>70</volume><issue>4</issue><spage>305</spage><epage>313</epage><pages>305-313</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>Summary The epidemiology of meticillin-resistant S. aureus (MRSA) infection has changed remarkably in recent years with the appearance of new MRSA strains causing infections in the community. These strains have now begun to cause healthcare-associated infections. The ability to track such changes is necessary to guide clinical and public health action. Here we report passive surveillance of all public laboratory susceptibility data in Queensland to track changes in MRSA phenotypes corresponding to the major epidemic strains from 2000 to 2006. The inpatient rate of MRSA isolation from pus, tissue and fluid (PTF) and blood culture (BC) specimens declined by 26% and 35%, respectively. The rate of isolation of the AUS-2/3-like phenotype (corresponding to ST239-MRSA-III) decreased from 651 to 242 isolates per million accrued patient days in inpatient PTF and BC, whereas that for non-multiresistant MRSA (nmMRSA, corresponding to community MRSA strains) increased from 71 to 315. The overall outpatient rate of MRSA isolation from PTF and BC increased by 224% and 31%, respectively. The rate of AUS-2/3-like isolates in outpatient PTF decreased from 131 to 60 per million outpatient occasions of service while the nmMRSA rate increased from 52 to 490. Surveillance of phenotypes derived from routine susceptibility data is a useful tool for tracking changes in the epidemiology of MRSA over large geographical regions.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><pmid>18783847</pmid><doi>10.1016/j.jhin.2008.07.003</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0195-6701
ispartof The Journal of hospital infection, 2008-12, Vol.70 (4), p.305-313
issn 0195-6701
1532-2939
language eng
recordid cdi_proquest_miscellaneous_69821963
source MEDLINE; Elsevier ScienceDirect Journals Complete
subjects Anti-Bacterial Agents - pharmacology
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Australia
Biological and medical sciences
Community-Acquired Infections - epidemiology
Community-Acquired Infections - microbiology
Cross Infection - epidemiology
Cross Infection - microbiology
Epidemiology
Humans
Infectious Disease
Infectious diseases
Medical sciences
Methicillin - pharmacology
Methicillin-Resistant Staphylococcus aureus - drug effects
Methicillin-Resistant Staphylococcus aureus - isolation & purification
Meticillin-resistant S. aureus
Microbial Sensitivity Tests
Pharmacology. Drug treatments
Phenotype
Population Surveillance - methods
Queensland - epidemiology
Staphylococcal Infections - epidemiology
Staphylococcal Infections - microbiology
Staphylococcus aureus - drug effects
Staphylococcus aureus - isolation & purification
Surveillance
title Changing epidemiology of meticillin-resistant S. aureus in Queensland, Australia, 2000–2006: use of passive surveillance of susceptibility phenotypes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T13%3A28%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changing%20epidemiology%20of%20meticillin-resistant%20S.%20aureus%20in%20Queensland,%20Australia,%202000%E2%80%932006:%20use%20of%20passive%20surveillance%20of%20susceptibility%20phenotypes&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Nimmo,%20G.R&rft.date=2008-12-01&rft.volume=70&rft.issue=4&rft.spage=305&rft.epage=313&rft.pages=305-313&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2008.07.003&rft_dat=%3Cproquest_cross%3E69821963%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69821963&rft_id=info:pmid/18783847&rft_els_id=1_s2_0_S0195670108003034&rfr_iscdi=true